WO1999024005A1 - Oral cleansing: methods and compositions - Google Patents
Oral cleansing: methods and compositions Download PDFInfo
- Publication number
- WO1999024005A1 WO1999024005A1 PCT/US1998/023682 US9823682W WO9924005A1 WO 1999024005 A1 WO1999024005 A1 WO 1999024005A1 US 9823682 W US9823682 W US 9823682W WO 9924005 A1 WO9924005 A1 WO 9924005A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition according
- acid
- mouth
- sequestrant
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the field of the invention is ingestible oral cleansing compositions.
- the present invention relates to edible oral cleansing and sanitizing compositions and the use of these compositions for reducing plaque and calculus deposition in the mouth and improving oral cleanliness and tooth smoothness.
- the active ingredients include safe and effective amounts of one or more members selected from each of three classes of cleansing and sanitizing agents, namely surfactants, sequestrants (chelators), and protein flocculators (coagulants/denaturants/precipitants), and optionally, one or more stimulators of saliva flow and osmotically active substances capable of plasmolysis of bacteria.
- hard candies comprising between about 0.01 and 20% surfactant, especially an alkyl sulfate such as sodium lauryl sulfate, between about 0.01 and 10% sequestrant, especially a polycarboxylic acid such as citric acid, and between about 0.01 and 10% protein flocculant, especially tannic acid are provided.
- the stimulation of saliva flow being induced either by acidity, provided for example by a polycarboxylic acid, such as citric acid (between 0.1 and 10%), and/or resulting from the masticatory activity implied by a chewing gum vehicle.
- the requisite active ingredients may be provided by fewer than five separate compounds (i.e. one compound may provide a plurality of active ingredients).
- citric acid can provide both the sequestrant and the stimulator of salivary flow.
- Sugars and/or sugar alcohols (between about 60 and 99%) which make up the hard candy or are made part of the chewing gum formulation serve in the osmotic role.
- compositions comprise a surfactant, a protein flocculator, a sequestrant, and optionally, a stimulator of saliva flow, and an osmotically active substance, which together serve to remove residual tastes from the palate, eliminate food and oral debris, reduce the size of the oral microbial flora, and inhibit plaque and calculus deposition.
- the compositions may further comprise inactive ingredients. All ingredients may be ingested and preferably are U.S.
- the disappearance of old coffee, onion, and garlic tastes and oily films from the oral cavity is startlingly obvious. Users appreciate the substitution of a clean taste, for the typical minty aftertaste of dentifrices and after dinner candies.
- the active ingredients are believed to function as follows. Surfactants dislodge food residues, plaque, and bacteria from oral surfaces and bring them into suspension. They also kill bacteria by disrupting their cell membranes and, in the presence of salivary lysozyme, facilitate bacterial cell lysis. Protein precipitants/flocculators denature and/or competitively remove proteins from teeth so they can more easily be brought into suspension, kill bacteria by reacting with bacterial membrane proteins and disrupt plaque and calculus deposition.
- Sequestrants destabilize the structures of food materials and oral debris, inhibit the calcification of plaque by demineralization (making it more vulnerable to the abrasive actions of brushing and flossing) and kill bacteria by destabilizing bacterial cell membranes through the removal of metal ions.
- Osmotically active substances facilitate the disruption of bacteria through plasmolysis.
- the stimulation of saliva flow by gustatory and masticatory signals results in a more fluid saliva, due to the increased proportion of parotid saliva in the salivary mix, increasing solvent action and adding a number of cleansing, sanitation and protection components, including lysozyme, peroxidase, lactoferrin, lectins, immunoglobulins, calcium phosphate (for remineralization), fluoride, etc. Swallowing the resulting suspension effectively cleans the oral cavity.
- compositions generally comprise between about 0.01 and 20%, preferably between about 0.05 and 5%, more preferably between about 0.1 and 2% by weight surfactant, or mixtures thereof, depending on the specific surfactant(s) used, including anionic, cationic, nonionic and zwitterionic species. Suitable concentrations are readily determined empirically in consideration of oral tolerance and palatability.
- Exemplary surfactants include monoglycerides and diglycerides, monoglyceride sulfonates, other fatty acid esters, fatty acids and their water- soluble salts, alkyl sulfates and their salts, polysorbates, alkyl quaternary ammonium compounds, alkyl sulfoacetates and their salts, alkyl polyglycol ether carboxylates, polyoxyethylene and polyoxybutylenes and copolymers, phosphonates, prooxylated cetyl alcohol, etc.
- Preferred surfactants include sodium alkyl sulfates and sulfoacetates, sodium lauryl sulfate, sodium lauryl sarcosinate, polyetheleneglycol stearate, and monoglyceride sulfonates; more preferred surfactants include sodium lauryl sulfate, sodium lauryl sarcosinate; and most preferred surfactants include sodium lauryl sulfate (SLS).
- SLS sodium lauryl sulfate
- compositions generally comprise between about 0.01 and 10%, preferably between about 0.05 and 1%, more preferably between about 0.1 and 0.5% by weight protein precipitant (or flocculant or denaturant), or mixtures thereof, depending on the specific protein precipitant(s) used and proportion of other components. Suitable concentrations are readily determined empirically in consideration of oral tolerance and palatability.
- Preferred precipitants are large polyionic molecules which displace the proteinaceous pellicle from the teeth and form linkages with and among proteins.
- Preferred precipitants include xanthan gum, gum tragacanth, guar gum, gum karaya, polygalacturonic acid, alginic acid, carrageenans, chondroitin sulfate, protamine sulfate, tannic acid, etc., and salts thereof, especially chondroitin sulfate, protamine sulfate, tannic acid and salts thereof.
- compositions generally comprise between about 0.01 and 10%, preferably between about 0.05 and 5%, more preferably between about 0.2 and 2% by weight sequestrant (chelator), or mixtures thereof, depending on the specific sequestrant(s) used and proportion of other components. Suitable concentrations are readily determined empirically in consideration of oral tolerance and palatability.
- sequestrants include polycarboxylic acid and their salts and esters, disodium ethylene diamine tetra acetic acid (disodium EDTA), salts of phosphoric acid and pyrophophoric acid, etc.
- Preferred sequestrants include citric and tartaric acids.
- compositions may also comprise other ingredients of varieties and concentrations commonly found in commercial hard candies, lozenges, gums, etc. These include one or more sweeteners such as sugars, sugar alcohols and artificial sweetners, e.g. sucrose, corn syrup, sorbitol, manitol, sodium cyclamate, saccharine, aspartame, xylitol, etc.
- sweeteners such as sugars, sugar alcohols and artificial sweetners, e.g. sucrose, corn syrup, sorbitol, manitol, sodium cyclamate, saccharine, aspartame, xylitol, etc.
- Caloric sugar sweeteners are generally are present at between about 30 and 99%, preferably between about 60 and 98% by weight, and more preferably between about 80 and 96% by weight.
- a wide variety of other compounds may be present so long as they are not incompatible with the intended use of the compositions, e.g.
- Exemplary additional compounds include a source of fluoride, humectants, preservatives (e.g. sodium benzoate) flavoring agents, gums, extenders, binders and other materials whose purposes are to improve product manufacture, product stability, and palatability.
- the subject compounds are also at least partially hydrated, i.e. they contain at least about 1 %, preferably at least about 2%, more preferably at least about 4% water, though water content is not considered in the concentration-expressed ranges herein.
- hard candies are the preferred formulation other delivery systems amenable to implementing the edible dimension of this invention are encompassed by it, for example, other candies (soft, lozenges, tablets, etc.) gums (see, e.g. US Pat No.5380530), liquids (sprays, rinses, beverages, etc.), etc.
- Hard candies of the invention are typically formulated for a total weight of 1-8 g, preferably 2-4 g.
- Orally administered liquids such as rinses preferably have a pH of between 5 and 10, more preferably between 5.5 and 9.5, most preferably between 6 and 8.
- Formulations were demonstrated to (1) produce subjectively smooth feeling teeth and a clean tasting mouth (2) reduce both preexisting calculus and plaque and the formation of new deposits and (3) result in a 10,000-fold reduction in bacterial flora of the oral cavity (as determined by blood agar cultures).
- formulation #1 4 g hard candy of either formulation #1 (supra), #2 ⁇ ,, #2 ⁇ 2 or #2 ⁇ 3 , was dissolved orally four times daily over 2 weeks. The candies were administered immediately after each of three meals and immediately after a late evening tooth brushing.
- Formulation #2 ⁇ was identical to formulation #2 except for the omission of sodium lauryl sulfate
- formulation #2 ⁇ 2 was identical to formulation #2 except for the omission of tannic acid
- formulation #2 ⁇ 3 was identical to formulation #2 except for the omission of citrate.
- Formulation #3 ⁇ ] is identical to formulation #3 except for the omission of sodium lauryl sarcosinate; #3 ⁇ 2 is identical to #3 except for the omission of chondroitin sulfate, and; #3 ⁇ 3 is identical to #3 except for the omission of tartaric acid.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU13848/99A AU740955B2 (en) | 1997-11-06 | 1998-11-06 | Oral cleansing: methods and compositions |
| NZ504858A NZ504858A (en) | 1997-11-06 | 1998-11-06 | Oral cleansing composition comprising sequestrants such as EDTA, surfactants and a protein flocculant such as chrondroitin sulphate, proteamine sulphate or tannic acid |
| AT98957639T ATE216872T1 (en) | 1997-11-06 | 1998-11-06 | ORAL CLEANSER PRODUCTS: METHODS AND COMPOSITIONS |
| EP98957639A EP1028702B1 (en) | 1997-11-06 | 1998-11-06 | Oral cleansing: methods and compositions |
| JP2000520100A JP4081740B2 (en) | 1997-11-06 | 1998-11-06 | Mouth washing method and composition |
| DE69805201T DE69805201T2 (en) | 1997-11-06 | 1998-11-06 | ORAL CLEANER: METHOD AND COMPOSITION |
| IL13597998A IL135979A (en) | 1997-11-06 | 1998-11-06 | Oral cleansing methods and compositions |
| CA002309351A CA2309351C (en) | 1997-11-06 | 1998-11-06 | Oral cleansing: methods and compositions |
| HK01105085.4A HK1034458B (en) | 1997-11-06 | 1998-11-06 | Oral cleansing: methods and compositions |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/965,344 | 1997-11-06 | ||
| US08/965,344 US5843471A (en) | 1997-11-06 | 1997-11-06 | Oral cleansing: methods and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999024005A1 true WO1999024005A1 (en) | 1999-05-20 |
Family
ID=25509837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1998/023682 Ceased WO1999024005A1 (en) | 1997-11-06 | 1998-11-06 | Oral cleansing: methods and compositions |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US5843471A (en) |
| EP (1) | EP1028702B1 (en) |
| JP (1) | JP4081740B2 (en) |
| KR (1) | KR100415169B1 (en) |
| CN (1) | CN1121851C (en) |
| AT (1) | ATE216872T1 (en) |
| AU (1) | AU740955B2 (en) |
| CA (1) | CA2309351C (en) |
| DE (1) | DE69805201T2 (en) |
| IL (1) | IL135979A (en) |
| NZ (1) | NZ504858A (en) |
| WO (1) | WO1999024005A1 (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843471A (en) * | 1997-11-06 | 1998-12-01 | Chaykin; Sterling | Oral cleansing: methods and compositions |
| CN100374110C (en) * | 1998-04-21 | 2008-03-12 | 瑞克尔科感染公司 | Topical formulations containing poloxamers and other microbicides, and applicators |
| EP1214106B1 (en) * | 1999-09-22 | 2003-11-19 | Baxter International Inc. | Cardiac valve and method for preparing a biological tissue |
| US7041277B2 (en) * | 2000-03-10 | 2006-05-09 | Cadbury Adams Usa Llc | Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| US20010043941A1 (en) * | 2000-03-23 | 2001-11-22 | Hiep Huatan | Oral formulations of medicaments |
| US6572374B2 (en) | 2000-06-13 | 2003-06-03 | Advantage Dental Products, Inc. | Dental bonding formulation complexing calcified deposits associated with a dentinal tubule opening |
| US7465295B2 (en) * | 2000-10-20 | 2008-12-16 | Bergeron Michel G | Applicator for the delivery of topical formulations into mucosal cavities |
| US8444958B2 (en) * | 2001-02-28 | 2013-05-21 | Ezaki Glico Co., Ltd. | Compositions having anti-dental caries function |
| US6482396B1 (en) | 2001-05-15 | 2002-11-19 | Campina Melkunie B.V. | Methods for treating or preventing diseases of the oral cavity |
| WO2003055459A1 (en) * | 2001-12-25 | 2003-07-10 | Kao Corporation | Composition for mouth |
| MXPA04006542A (en) * | 2002-01-03 | 2004-10-04 | Procter & Gamble | Stable oral compositions comprising casein phosphopeptide complexes and flouride. |
| FR2838339B1 (en) * | 2002-04-12 | 2005-06-24 | Univ Angers | POLYPHOSPHONATE DERIVATIVES FOR DENTIFRING COMPOSITIONS |
| KR20030089047A (en) * | 2002-05-16 | 2003-11-21 | 주식회사 엘지생활건강 | Composition for enhancing oral health |
| US6685916B1 (en) * | 2002-10-31 | 2004-02-03 | Cadbury Adams Usa Llc | Compositions for removing stains from dental surfaces, and methods of making and using the same |
| US7041311B2 (en) * | 2003-02-28 | 2006-05-09 | International Flavors & Fragrances Inc. | Preparation for saliva flow |
| FR2860154B1 (en) * | 2003-09-29 | 2006-02-03 | Chris Cardon | COMPOSITION FOR THE TREATMENT OF MALE BREATH |
| KR101011049B1 (en) * | 2009-07-20 | 2011-01-25 | 김홍철 | Dental oral liquid compositions and alpha-hydroxy acids that contain coagulated products after gargle |
| KR101685259B1 (en) | 2014-12-02 | 2016-12-09 | 임인자 | Oral Cavity Cleaning Composition |
| CN107714611A (en) * | 2017-11-13 | 2018-02-23 | 常州麒通国际贸易有限公司 | A kind of edible toothpaste for children |
| KR20190098391A (en) | 2018-02-14 | 2019-08-22 | 주식회사 테코자임 | Film and Denture for eliminating halitosis |
| US12447119B2 (en) | 2019-03-18 | 2025-10-21 | Sunstar Americas, Inc. | Oral care composition |
| TR2023018280A2 (en) * | 2023-12-25 | 2024-01-22 | Bursa Uludag Ueniversitesi | A BIOACTIVE CAVITY DISINFECTANT |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4170633A (en) * | 1977-11-28 | 1979-10-09 | General Mills, Inc. | Plaque inhibiting composition and method |
| JPS5569508A (en) * | 1978-11-20 | 1980-05-26 | Sunstar Inc | Toothpaste composition |
| GB2141340A (en) * | 1983-06-06 | 1984-12-19 | G C Dental Ind Corp | Dental composition |
| JPS63253018A (en) * | 1987-04-09 | 1988-10-20 | Sunstar Inc | Composition for oral cavity |
| EP0413056A1 (en) * | 1988-02-23 | 1991-02-20 | Nippon Hypox Laboratories Incorporated | Method for reducing astringency and bitterness of tannic acid |
| WO1995031174A1 (en) * | 1994-05-13 | 1995-11-23 | The Procter & Gamble Company | Oral compositions |
| US5614207A (en) * | 1995-06-30 | 1997-03-25 | Mcneil-Ppc, Inc. | Dry mouth lozenge |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633960A (en) * | 1962-06-22 | |||
| JPS53148542A (en) * | 1977-05-27 | 1978-12-25 | Reiichi Yamaga | Pharmaceutical composition densistry |
| JPS5846483B2 (en) * | 1979-09-20 | 1983-10-17 | ライオン株式会社 | Oral composition |
| US4273758A (en) * | 1979-11-06 | 1981-06-16 | Weilin Liau | Dentifrice and its method of manufacture |
| JPS56139423A (en) * | 1980-04-02 | 1981-10-30 | Toyo Seiyaku Kasei Kk | Hemostatic agent for dental oral use |
| US4301178A (en) * | 1980-05-02 | 1981-11-17 | Life Savers, Inc. | Liquid-filled chewing gum and method |
| JPS5838208A (en) * | 1981-08-29 | 1983-03-05 | Sunstar Inc | Tannin-containing composition for oral cavity |
| US4386106A (en) * | 1981-12-01 | 1983-05-31 | Borden, Inc. | Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition |
| US4515769A (en) * | 1981-12-01 | 1985-05-07 | Borden, Inc. | Encapsulated flavorant material, method for its preparation, and food and other compositions incorporating same |
| US4855128A (en) * | 1988-01-14 | 1989-08-08 | Warner-Lambert Company | Saccharide inhibition of dental plaque |
| US5143720A (en) * | 1990-11-28 | 1992-09-01 | Microcide, Inc. | Disinfecting and sanitizing compositions |
| US5250569A (en) * | 1991-04-22 | 1993-10-05 | Godfrey Science & Design, Inc. | Amino acid flavorings of aluminum astringent for oral use |
| JPH06153800A (en) * | 1992-11-19 | 1994-06-03 | Kanebo Ltd | Chewy confectionery |
| US5380530A (en) * | 1992-12-29 | 1995-01-10 | Whitehill Oral Technologies | Oral care composition coated gum |
| US5554410A (en) * | 1994-05-10 | 1996-09-10 | Warner-Lambert Company | Delivery of fruit juice, acidulants, and labile components into cooked candy base |
| JPH08291013A (en) * | 1995-04-19 | 1996-11-05 | Mitsui Norin Kk | Composition comprising activated carbon and plant polyphenols |
| JPH09327504A (en) * | 1996-06-11 | 1997-12-22 | Maruzen Pharmaceut Co Ltd | Deodorant |
| US5882702A (en) * | 1996-10-07 | 1999-03-16 | Warner-Lambert Company | Process for the formation of plasticized proteinaceous materials and compositions containing the same |
| US5843471A (en) * | 1997-11-06 | 1998-12-01 | Chaykin; Sterling | Oral cleansing: methods and compositions |
-
1997
- 1997-11-06 US US08/965,344 patent/US5843471A/en not_active Expired - Lifetime
-
1998
- 1998-11-06 CN CN98811910A patent/CN1121851C/en not_active Expired - Fee Related
- 1998-11-06 IL IL13597998A patent/IL135979A/en not_active IP Right Cessation
- 1998-11-06 AU AU13848/99A patent/AU740955B2/en not_active Ceased
- 1998-11-06 DE DE69805201T patent/DE69805201T2/en not_active Expired - Lifetime
- 1998-11-06 KR KR10-2000-7004920A patent/KR100415169B1/en not_active Expired - Fee Related
- 1998-11-06 JP JP2000520100A patent/JP4081740B2/en not_active Expired - Fee Related
- 1998-11-06 WO PCT/US1998/023682 patent/WO1999024005A1/en not_active Ceased
- 1998-11-06 EP EP98957639A patent/EP1028702B1/en not_active Expired - Lifetime
- 1998-11-06 AT AT98957639T patent/ATE216872T1/en active
- 1998-11-06 NZ NZ504858A patent/NZ504858A/en unknown
- 1998-11-06 CA CA002309351A patent/CA2309351C/en not_active Expired - Fee Related
- 1998-11-11 US US09/189,563 patent/US6013274A/en not_active Expired - Lifetime
-
1999
- 1999-11-01 US US09/431,193 patent/US6090402A/en not_active Expired - Lifetime
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4170633A (en) * | 1977-11-28 | 1979-10-09 | General Mills, Inc. | Plaque inhibiting composition and method |
| JPS5569508A (en) * | 1978-11-20 | 1980-05-26 | Sunstar Inc | Toothpaste composition |
| GB2141340A (en) * | 1983-06-06 | 1984-12-19 | G C Dental Ind Corp | Dental composition |
| JPS63253018A (en) * | 1987-04-09 | 1988-10-20 | Sunstar Inc | Composition for oral cavity |
| EP0413056A1 (en) * | 1988-02-23 | 1991-02-20 | Nippon Hypox Laboratories Incorporated | Method for reducing astringency and bitterness of tannic acid |
| WO1995031174A1 (en) * | 1994-05-13 | 1995-11-23 | The Procter & Gamble Company | Oral compositions |
| US5614207A (en) * | 1995-06-30 | 1997-03-25 | Mcneil-Ppc, Inc. | Dry mouth lozenge |
Non-Patent Citations (2)
| Title |
|---|
| PATENT ABSTRACTS OF JAPAN vol. 004, no. 106 (C - 020) 30 July 1980 (1980-07-30) * |
| PATENT ABSTRACTS OF JAPAN vol. 013, no. 061 (C - 567) 10 February 1989 (1989-02-10) * |
Also Published As
| Publication number | Publication date |
|---|---|
| IL135979A (en) | 2002-09-12 |
| EP1028702A1 (en) | 2000-08-23 |
| IL135979A0 (en) | 2001-05-20 |
| ATE216872T1 (en) | 2002-05-15 |
| DE69805201D1 (en) | 2002-06-06 |
| CA2309351C (en) | 2003-05-27 |
| AU1384899A (en) | 1999-05-31 |
| EP1028702B1 (en) | 2002-05-02 |
| NZ504858A (en) | 2001-10-26 |
| CN1121851C (en) | 2003-09-24 |
| US6090402A (en) | 2000-07-18 |
| US6013274A (en) | 2000-01-11 |
| KR100415169B1 (en) | 2004-01-14 |
| HK1034458A1 (en) | 2001-10-26 |
| CA2309351A1 (en) | 1999-05-20 |
| JP2001522788A (en) | 2001-11-20 |
| DE69805201T2 (en) | 2002-12-12 |
| AU740955B2 (en) | 2001-11-15 |
| US5843471A (en) | 1998-12-01 |
| JP4081740B2 (en) | 2008-04-30 |
| KR20010031847A (en) | 2001-04-16 |
| CN1281353A (en) | 2001-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2309351C (en) | Oral cleansing: methods and compositions | |
| US6083527A (en) | Breath mint with tooth decay and halitosis prevention characteristics | |
| US4775525A (en) | Oral hygiene formulation containing sodium alginate | |
| KR100296414B1 (en) | Antibacterial Mouthwash | |
| US20080057007A1 (en) | Oral hygiene products containing ascorbic acid and method of using the same | |
| JPS63190817A (en) | Oral sanitary medicine | |
| US6071500A (en) | Breath spray with tooth decay and halitosis prevention characteristics | |
| US7189351B2 (en) | D-tagatose as an anti-biofilm agent | |
| US6231836B1 (en) | Folic acid dentifrice | |
| US10493302B2 (en) | Compositions for human dental care | |
| CN111544319A (en) | Toothpaste capable of inhibiting helicobacter pylori and preparation method thereof | |
| US6861047B1 (en) | Oral hygiene preparations; associated methods and kit | |
| MX2007007201A (en) | Oral compositions for prevention and reduction of bacterial adhesion to oral surfaces. | |
| US20190008746A1 (en) | Oral Hygiene Products and Method of Using the Same | |
| JPH02250815A (en) | Anticarious agent, anticarious composition for oral cavity application and food or drink having anticarious function | |
| HK1034458B (en) | Oral cleansing: methods and compositions | |
| CN101115506B (en) | Oral treatment composition containing anti-adhesive, antimicrobial and incompatible compounds | |
| Mor et al. | PLAQUE CONTROL AND PREVENTION | |
| RAJATMATHUR | Healthy Teeth Dazzling Smile | |
| KR19990053086A (en) | Toothpaste composition with improved irritation and usability | |
| JP2003252738A (en) | Dentifrice composition | |
| WO1999004755A1 (en) | Tongue wash |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WWE | Wipo information: entry into national phase |
Ref document number: 135979 Country of ref document: IL Ref document number: 98811910.2 Country of ref document: CN |
|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 1020007004920 Country of ref document: KR |
|
| ENP | Entry into the national phase |
Ref document number: 2309351 Country of ref document: CA Ref document number: 2309351 Country of ref document: CA Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 2000 520100 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 13848/99 Country of ref document: AU |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1998957639 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 504858 Country of ref document: NZ |
|
| WWP | Wipo information: published in national office |
Ref document number: 1998957639 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: 1020007004920 Country of ref document: KR |
|
| WWG | Wipo information: grant in national office |
Ref document number: 13848/99 Country of ref document: AU |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1998957639 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1020007004920 Country of ref document: KR |

